For the seventh straight night, US aircraft, drones, and warships struck Iran on July 17, hitting surveillance sites, weapons storage, bridges, and railway lines across Hormozgan province, and a maritime control tower at Chabahar port on the Gulf of Oman. Defense Secretary Pete Hegseth posted photos of the collapsed tower to social media. Iranian health officials report the week's campaign has killed at least 38 people and wounded over 400. Iran responded with strikes across the region: a missile hit a Kuwaiti water desalination plant, injuring several soldiers; attacks on at least two Jordanian military bases injured several US service members; and IRGC drones struck a US drone depot in Bahrain. Senior IRGC commander Mohsen Rezaei warned that Iran "will no longer limit itself to retaliatory, like-for-like responses" and that "no political border will be safe." An unnamed IRGC official added that if US strikes continue for two to three more days, Iran will move to "full-scale offensive operations."
The current fighting resumed July 7 when Trump declared the June ceasefire "over" after the IRGC attacked three commercial ships near Oman. That ceasefire followed the US killing of Supreme Leader Khamenei in Operation Epic Fury (February 2026) and a US naval blockade of the Strait of Hormuz. The strait handles roughly a quarter of global maritime oil trade.
Ukrainian President Zelensky fired Defence Minister Mykhailo Fedorov on July 16 after a conflict with Commander-in-Chief Gen. Oleksandr Syrsky became irreconcilable. Zelensky kept Syrsky, and Fedorov, who had publicly accused the general of "fuelling divisions" and "incompetence," was dismissed. The firing triggered protests in Kyiv, Lviv, Odesa, and Dnipro — crowds chanting "Shame!" outside Kyiv's Ivan Franko theatre — and Air Force Deputy Commander Pavlo Yelizarov resigned in protest, calling it "a great blow to the country's defense capability." Fedorov had served as minister for just six months; acting minister Maj. Gen. Yevhenii Khmara, a former Security Service commander, replaced him. Zelensky is expected to nominate Interior Minister Ihor Klymenko permanently. BBC reporting says many frontline soldiers share the protesters' anger, viewing Fedorov as the architect of Ukraine's drone warfare edge.
Fedorov built his reputation as minister of digital transformation before taking defence. He pioneered Ukraine's drone warfare strategy, persuaded Elon Musk to disable Starlink terminals used by Russian forces, and introduced procurement transparency reforms. A public split of this kind between senior officials is rare in Ukraine's wartime government.
Astronomers confirmed for the first time that a rocky, potentially habitable planet retains an atmosphere — detecting helium escaping from LHS 1140b, a super-Earth roughly 48 light-years away orbiting in its star's habitable zone. The discovery, published July 16 in Science and led by Dr. Shreyas Vissapragada at Carnegie Science Observatories, used the WINERED spectrograph at the Magellan Clay telescope in Chile. Detecting helium leaking off a planet confirms it holds a measurable atmosphere; heavier molecules like CO2 and water vapor are expected at lower altitudes, trapped below the escaping lighter gas. If greenhouse gases are present in sufficient quantities, surface temperature could rise above freezing despite an equilibrium of around -47 degrees Celsius. JWST and Hubble are scheduled to observe LHS 1140b over the next four to five years, hunting for water vapor and CO2 signatures directly.
Nearly all confirmed atmospheres to date belong to gas giants or hot, uninhabitable planets. LHS 1140b orbits in the habitable zone of an M-dwarf star — the most common stellar type in the galaxy — and was first discovered in 2016. Helium detection varied between 2024 and 2025 observations, suggesting the atmosphere fluctuates with stellar radiation cycles. Lead author Jason Dittmann: "This is the first time we're seeing a rocky, Earth-like planet that could still have an atmosphere."
Isomorphic Labs, a drug discovery company spun out of Google DeepMind, released IsoDDE on July 17 — a unified AI system that goes past what AlphaFold predicts. AlphaFold predicts how proteins fold into their 3D shapes; IsoDDE adds three capabilities the pharmaceutical industry currently relies on expensive physics-based methods to handle: predicting how tightly a drug molecule binds to its target, modeling antibody-antigen interactions at more than double AlphaFold 3's accuracy, and identifying cryptic binding pockets on proteins that only become accessible when a drug attaches. On binding affinity, IsoDDE outperforms FEP — free energy perturbation, the gold standard used in pharmaceutical labs — in both speed and accuracy. Isomorphic expects the first drug candidates built on this pipeline to enter clinical trials by end of 2026. Active pharmaceutical partners include Novartis, Eli Lilly, and Johnson and Johnson.
AlphaFold, also from DeepMind, predicted the 3D shapes of nearly all known proteins and earned its founders the Nobel Prize in Chemistry in 2024. Structure prediction is the first step in drug discovery. Determining which molecules bind tightly to a target — and how tightly — is the harder downstream step that governs whether a candidate is worth synthesizing in a lab.
Moonshot AI (月之暗面), a Beijing-based startup, launched Kimi K3 on July 16 — a 2.8-trillion-parameter mixture-of-experts language model that the company benchmarks above Claude Opus 4.8 and GPT-5.5 on coding and general agent tasks. Arena ratings also place K3 ahead of Opus 4.8 on text. Casey Newton at Platformer describes it as a meaningful capability step, but cautions the hype is outrunning the evidence. Independent testing found accuracy improved from 33% to 46% over the previous Kimi generation — but the hallucination rate climbed simultaneously from 39% to 51%. The full open-weight release, promised at launch, is still pending on Hugging Face until July 27. API prices tripled. K3 still trails Claude Fable 5 and GPT-5.6 Sol at the top of overall rankings. The gap between Chinese and US frontier models has closed substantially over the past year, and K3 is another step in that direction.
Chinese AI labs have been the fastest-moving challengers to US frontier models since DeepSeek's releases in early 2025. Kimi K3's mixture-of-experts architecture activates only a fraction of its 2.8 trillion parameters at once, making it cheaper to run than a dense model of comparable total size. Moonshot AI is an independent Beijing startup, not a division of Alibaba, Tencent, or Baidu.
The Trump administration finalized a rule on July 16 capping F-1 student and J exchange visitor visa holders to a four-year maximum stay in the US. Previously, both categories allowed students to remain for the "duration of status" — however long their enrolled program required. The rule takes effect in mid-September 2026. Students who need more than four years must apply to DHS for an extension; PhD programs routinely require five to seven years, making a four-year cap structurally incompatible with degree completion without extension filings. Students who leave the US after mid-September lose the four-year grandfather protection. The rule also requires federal approval for mid-program school transfers or degree changes. DHS framed the change as ending "foreign student visa abuse." NAFSA, the international student services organization, called it "a solution in search of a problem" and noted F and J holders are "already one of the most closely monitored nonimmigrant groups."
F-1 visas cover nearly one million international students at US universities; J visas cover exchange scholars and research fellows. Graduate programs in engineering, computer science, and the natural sciences rely heavily on international enrollment. PhD students often require extensions even under the existing system due to research timelines and dissertation revisions.
The European Commission issued two binding orders against Google on July 16 under the Digital Markets Act, requiring the company to share search data and open Android to rival AI assistants. On search: starting January 2027, Google must anonymize and share query, click, ranking, and view data from Google Search with competitors including OpenAI and Microsoft. On Android: starting with the next major Android release, expected July 2027, Google must grant third-party assistants — ChatGPT, Claude, and others — the same system-level device permissions currently exclusive to Gemini, including app interaction, hardware control, and background listening. Google's chief legal officer Kent Walker warned that sharing "Europeans' private searches to unfamiliar companies, without adequate anonymisation" creates serious privacy and security risks. The EU had rejected Google's last legal challenge to the Act on July 9.
The Digital Markets Act designates large platform operators as "gatekeepers" with interoperability obligations beyond ordinary antitrust law. Google is a designated gatekeeper in both search and mobile operating systems. The Android AI order targets the advantage Gemini gains from pre-installation with privileged system access — an arrangement that locks other AI assistants out of the device-level integration that feels native to Android users.
Columbia University biologist Martin Picard has spent the last decade building a theory that mitochondria — the organelles that produce cellular energy — are the central organizing principle of health, stress, and the experience of consciousness. His "energetic view of life" holds that the flow of electrons through metabolism represents "the most basic level of the experience of being alive." The case rests on concrete experiments: in mice with engineered mitochondrial defects, stress responses differed measurably from mice with healthy mitochondria. A 2025 brain mapping study he co-authored found wide variation in mitochondrial density across brain regions and cell types, describing a "molecular energetic landscape" underlying thought. In patients with rare mitochondrial diseases, metabolic chambers measured 180 extra calories burned per day alongside elevated fatigue. Mitochondria also synthesize neurotransmitter precursors, regulate calcium, and produce steroid hormones — processes that directly shape mood, sleep, and stress response.
Mitochondria descended from ancient bacteria absorbed into early cells and retain their own genome. Mainstream medicine frames disease primarily through genes and proteins. Picard argues that changes in mitochondrial function, not just structure, explain large parts of mental health, stress resilience, and aging. Colleagues initially dismissed the work as "woo"; the leap from mitochondria affecting brain chemistry to mitochondria underlying consciousness remains contested.
The FDA approved enlicitide, brand name Lipfendra, on July 16 — the first oral PCSK9 inhibitor and a new category of cholesterol-lowering pill that outperforms statins on LDL reduction. The drug works by blocking PCSK9, a liver protein that slows the body's ability to clear LDL cholesterol from the blood; blocking it lets the liver remove far more. In clinical trials, enlicitide cut LDL by up to 60% over six months, pushing levels to around 50 from a standard adult threshold above 100 — reaching the sub-55 target now recommended by the American Heart Association for high-risk patients. Statins, used for decades, can't reach those levels reliably. Manufacturer Merck, which discovered the first FDA-approved statin in 1987, priced enlicitide at $315 for a 30-day supply. Injectable PCSK9 inhibitors have existed for about a decade but faced insurance access barriers; the pill form removes the self-injection requirement.
LDL is a form of cholesterol that accumulates in artery walls, contributing to atherosclerosis and heart disease. Statins reduce the liver's cholesterol production, cutting LDL by 30-50% on average. The most at-risk patients often need further reduction to hit updated cardiology targets. PCSK9 inhibitors take a different route: they increase the liver's capacity to pull existing LDL out of the bloodstream rather than limiting production.
Around 40,000 workers at Hyundai Motor's Korean manufacturing plants began a partial strike on July 13 — refusing to work four hours per day — in what is described as the first factory stoppage in automotive history over humanoid robots. Boston Dynamics's Atlas robots, now owned by Hyundai, stand 6'2", can lift 110 lbs, and cost roughly $130,000 per unit with an estimated two-year payback period. Hyundai has committed to deploying Atlas at a nonunion plant in Georgia by 2028 for repetitive logistics tasks; no deployment date is set for Korean plants. The union's core demand is formal consent rights before Atlas arrives on factory floors — they want to negotiate before displacement, not after. Workers also want profit-sharing tied to annual earnings, a retirement age extension from 60 to 65, and income protections during automation expansion. Management responded by telling workers "past strikes have yielded nothing but irreversible production losses."
Atlas is built by Boston Dynamics, which Hyundai acquired in 2021. Toyota, Tesla, Mercedes-Benz, BMW, BYD, and Chery are all investing in similar humanoid robot deployments. At roughly a two-year payback period, the automation case is strong at the management level. The Hyundai strike is notable for being pre-emptive — Atlas hasn't been deployed in Korea yet — as workers seek to lock in protections before displacement is a fait accompli.
